$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

$ams Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-Q Financial Statement

#000074482519000008 Filed on November 07, 2019

Income Statement

Concept	2019 Q4	2019 Q3	2018 Q4
Revenue	$4.786M	$5.301M	$4.770M
YoY Change	0.34%	18.59%	-6.1%
Cost Of Revenue	$3.345M	$3.488M	$3.205M
YoY Change	4.37%	22.99%	10.52%
Gross Profit	$1.441M	$1.813M	$1.565M
YoY Change	-7.92%	10.95%	-28.21%
Gross Profit Margin	30.11%	34.2%	32.81%
Selling, General & Admin	$859.0K	$1.065M	$927.0K
YoY Change	-7.34%	1.43%	-9.12%
% of Gross Profit	59.61%	58.74%	59.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.639M	$1.839M	$1.680M
YoY Change	-2.44%	3.43%	3.07%
% of Gross Profit	113.74%	101.43%	107.35%
Operating Expenses	$859.0K	$1.065M	$927.0K
YoY Change	-7.34%	1.43%	-9.12%
Operating Profit	$582.0K	$446.0K	$638.0K
YoY Change	-8.78%	141.08%	-45.0%
Interest Expense	-$302.0K	$302.0K	-$397.0K
YoY Change	-23.93%	-24.31%	-34.92%
% of Operating Profit	-51.89%	67.71%	-62.23%
Other Income/Expense, Net
YoY Change
Pretax Income	$280.0K	$453.0K	$241.0K
YoY Change	16.18%	22.43%	-1305.0%
Income Tax	-$122.0K	$99.00K	$50.00K
% Of Pretax Income	-43.57%	21.85%	20.75%
Net Earnings	$193.0K	$165.0K	$178.0K
YoY Change	8.43%	-1.79%	-87.46%
Net Earnings / Revenue	4.03%	3.11%	3.73%
Basic Earnings Per Share		$0.03
Diluted Earnings Per Share	$30.00K	$0.03	$40.00K
COMMON SHARES
Basic Shares Outstanding	5.816M shares	5.889M shares	5.714M shares
Diluted Shares Outstanding		5.908M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.429M	$1.297M	$1.442M
YoY Change	-0.9%	-29.47%	-32.93%
Cash & Equivalents	$1.429M	$1.297M	$1.442M
Short-Term Investments
Other Short-Term Assets	$2.250M	$2.175M	$1.626M
YoY Change	38.38%	12.99%	7.68%
Inventory
Prepaid Expenses
Receivables	$6.894M	$6.511M	$5.502M
Other Receivables	$169.0K	$261.0K	$239.0K
Total Short-Term Assets	$10.74M	$10.24M	$9.946M
YoY Change	8.0%	7.45%	11.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$41.48M	$43.00M	$46.69M
YoY Change	-11.17%	-6.76%	-3.71%
Goodwill	$0.00
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$455.0K	$838.0K	$862.0K
YoY Change	-47.22%	2.82%	8.84%
Total Long-Term Assets	$43.04M	$45.01M	$47.56M
YoY Change	-9.49%	-4.09%	-3.5%
TOTAL ASSETS
Total Short-Term Assets	$10.74M	$10.24M	$9.946M
Total Long-Term Assets	$43.04M	$45.01M	$47.56M
Total Assets	$53.78M	$55.26M	$57.50M
YoY Change	-6.47%	-2.15%	-1.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$557.0K	$1.097M	$435.0K
YoY Change	28.05%	98.01%	21.17%
Accrued Expenses	$1.817M	$2.043M	$2.513M
YoY Change	-27.7%	32.49%	82.1%
Deferred Revenue
YoY Change
Short-Term Debt	$475.0K	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.526M	$1.666M	$2.119M
YoY Change	-27.98%	-19.59%	-13.83%
Total Short-Term Liabilities	$8.214M	$8.778M	$9.474M
YoY Change	-13.3%	-0.05%	5.18%
LONG-TERM LIABILITIES
Long-Term Debt	$1.954M	$2.230M	$3.332M
YoY Change	-41.36%	5.29%	-7.39%
Other Long-Term Liabilities	$1.113M	$1.203M	$382.0K
YoY Change	191.36%	194.85%	-23.6%
Total Long-Term Liabilities	$1.954M	$2.230M	$3.332M
YoY Change	-41.36%	5.29%	-7.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.214M	$8.778M	$9.474M
Total Long-Term Liabilities	$1.954M	$2.230M	$3.332M
Total Liabilities	$10.17M	$11.01M	$12.81M
YoY Change	-20.6%	0.99%	1.59%
SHAREHOLDERS EQUITY
Retained Earnings	$8.555M	$8.362M	$7.896M
YoY Change	8.35%	8.34%	14.88%
Common Stock	$17.48M	$17.42M	$17.21M
YoY Change	1.58%	1.55%	1.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.03M	$25.78M	$25.10M
YoY Change
Total Liabilities & Shareholders Equity	$53.78M	$55.26M	$57.50M
YoY Change	-6.47%	-2.15%	-1.16%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2018 Q4
OPERATING ACTIVITIES
Net Income	$193.0K	$165.0K	$178.0K
YoY Change	8.43%	-1.79%	-87.46%
Depreciation, Depletion And Amortization	$1.639M	$1.839M	$1.680M
YoY Change	-2.44%	3.43%	3.07%
Cash From Operating Activities	$1.920M	$1.914M	$1.837M
YoY Change	4.52%	183.56%	-35.99%
INVESTING ACTIVITIES
Capital Expenditures	-$101.0K	-$143.0K	-$390.0K
YoY Change	-74.1%	-63.98%	875.0%
Acquisitions
YoY Change
Other Investing Activities	-$160.0K	$0.00	$51.00K
YoY Change	-413.73%
Cash From Investing Activities	-$261.0K	-$143.0K	-$339.0K
YoY Change	-23.01%	-63.98%	747.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.527M	-2.380M	-1.895M
YoY Change	-19.42%	23.25%	-0.26%
NET CHANGE
Cash From Operating Activities	1.920M	1.914M	1.837M
Cash From Investing Activities	-261.0K	-143.0K	-339.0K
Cash From Financing Activities	-1.527M	-2.380M	-1.895M
Net Change In Cash	132.0K	-609.0K	-397.0K
YoY Change	-133.25%	-63.16%	-142.69%
FREE CASH FLOW
Cash From Operating Activities	$1.920M	$1.914M	$1.837M
Capital Expenditures	-$101.0K	-$143.0K	-$390.0K
Free Cash Flow	$2.021M	$2.057M	$2.227M
YoY Change	-9.25%	91.88%	-23.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	42000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2019-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0000744825
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Document Type DocumentType	10-Q
	dei	Entity Registrant Name EntityRegistrantName	American Shared Hospital Services
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5816000	shares
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1297000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1442000	USD
CY2019Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	350000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	350000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	100000	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6511000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5502000	USD
CY2019Q3	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	0	USD
CY2018Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	1137000	USD
CY2019Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	261000	USD
CY2018Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	239000	USD
CY2019Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1825000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1276000	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	10244000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	9946000	USD
CY2019Q3	ams	Deposits And Construction In Progress Gross DepositsAndConstructionInProgressGross	5589000	USD
CY2018Q4	ams	Deposits And Construction In Progress Gross DepositsAndConstructionInProgressGross	6082000	USD
CY2019Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	90672000	USD
CY2018Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	94031000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	578000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	589000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	96839000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	100702000	USD
CY2019Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	53836000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	54008000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43003000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46694000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1173000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	838000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	862000	USD
CY2019Q3	us-gaap	Assets Assets	55258000	USD
CY2018Q4	us-gaap	Assets Assets	57502000	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1097000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	435000	USD
CY2019Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	289000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	207000	USD
CY2019Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1482000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1329000	USD
CY2019Q3	ams	Other Accrued Liabilities Insurance Payable OtherAccruedLiabilitiesInsurancePayable	0	USD
CY2018Q4	ams	Other Accrued Liabilities Insurance Payable OtherAccruedLiabilitiesInsurancePayable	977000	USD
CY2019Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	272000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1666000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2119000	USD
CY2019Q3	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3972000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	4407000	USD
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8778000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9474000	USD
CY2019Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	901000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2230000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3332000	USD
CY2019Q3	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	8881000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	10308000	USD
CY2019Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	302000	USD
CY2018Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	382000	USD
CY2019Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2744000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	2958000	USD
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	10752000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	10711000	USD
CY2019Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6665000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6495000	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8362000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	7896000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	25779000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	25102000	USD
CY2019Q3	us-gaap	Minority Interest MinorityInterest	5643000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	5946000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31422000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31048000	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	55258000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57502000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5301000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4470000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15819000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14944000	USD
CY2019Q3	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	648000	USD
CY2018Q3	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	470000	USD
	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	1968000	USD
	us-gaap	Direct Operating Maintenance Supplies Costs DirectOperatingMaintenanceSuppliesCosts	1723000	USD
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1817000	USD
CY2018Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1761000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5719000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5082000	USD
CY2019Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1023000	USD
CY2018Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	605000	USD
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2653000	USD
	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	2218000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	3488000	USD
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	2836000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	10340000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	9023000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	1813000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	1634000	USD
	us-gaap	Gross Profit GrossProfit	5479000	USD
	us-gaap	Gross Profit GrossProfit	5921000	USD
CY2019Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1065000	USD
CY2018Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1050000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3201000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3067000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	302000	USD
CY2018Q3	us-gaap	Interest Expense InterestExpense	399000	USD
	us-gaap	Interest Expense InterestExpense	1015000	USD
	us-gaap	Interest Expense InterestExpense	1230000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	446000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	185000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1263000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	1624000	USD
CY2019Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	0	USD
CY2018Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	0	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	0	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	22000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1278000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1840000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	99000	USD
CY2019Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	7000	USD
CY2018Q3	us-gaap	Interest And Other Income InterestAndOtherIncome	185000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	15000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	194000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	453000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	370000	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	82000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	250000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	401000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	354000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	288000	USD
	us-gaap	Profit Loss ProfitLoss	1028000	USD
	us-gaap	Profit Loss ProfitLoss	1439000	USD
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	189000	USD
CY2018Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	120000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	562000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	594000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	165000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	168000	USD
	us-gaap	Net Income Loss NetIncomeLoss	466000	USD
	us-gaap	Net Income Loss NetIncomeLoss	845000	USD
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31048000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	55000	USD
CY2019Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	19000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	395000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31479000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	53000	USD
CY2019Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	57000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	279000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31754000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	62000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	41000	USD
CY2019Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	789000	USD
CY2019Q3	us-gaap	Profit Loss ProfitLoss	354000	USD
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31422000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29885000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	55000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	651000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	30591000	USD
CY2018Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	57000	USD
CY2018Q2	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	77000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	500000	USD
CY2018Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31071000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	57000	USD
CY2018Q3	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	393000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	288000	USD
CY2018Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31023000	USD
	us-gaap	Profit Loss ProfitLoss	1028000	USD
	us-gaap	Profit Loss ProfitLoss	1439000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5772000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5138000	USD
	ams	Non Cash Lease Expense NonCashLeaseExpense	189000	USD
	ams	Non Cash Lease Expense NonCashLeaseExpense	0	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-214000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	45000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	170000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	896000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	398000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	559000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	473000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	169000	USD
	ams	Net Accrued Interest On Lease Financing NetAccruedInterestOnLeaseFinancing	-9000	USD
	ams	Net Accrued Interest On Lease Financing NetAccruedInterestOnLeaseFinancing	-39000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	59000	USD
	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	-60000	USD
	us-gaap	Increase Decrease In Deferred Revenue And Customer Advances And Deposits IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits	-93000	USD
	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-248000	USD
	ams	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	0	USD
	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	-877000	USD
	ams	Increase Decrease In Accounts Payable Accrued Liabilities And Deferred Revenue IncreaseDecreaseInAccountsPayableAccruedLiabilitiesAndDeferredRevenue	-359000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6127000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6225000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	889000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1187000	USD
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	160000	USD
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-729000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1187000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1564000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1875000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3155000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3006000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	865000	USD
	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	470000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	41000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5543000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5351000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-145000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-313000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1792000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2502000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1647000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2189000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1015000	USD
	us-gaap	Interest Paid Net InterestPaidNet	1307000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	418000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	277000	USD
	ams	Non Cash Right Of Use Assets And Lease Liabilities NonCashRightOfUseAssetsAndLeaseLiabilities	1362000	USD
	ams	Non Cash Right Of Use Assets And Lease Liabilities NonCashRightOfUseAssetsAndLeaseLiabilities	0	USD
	ams	Interest Capitalized To Property And Equipment InterestCapitalizedToPropertyAndEquipment	82000	USD
	ams	Interest Capitalized To Property And Equipment InterestCapitalizedToPropertyAndEquipment	77000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	1293000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	1679000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2019Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	96839000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	100702000	USD
CY2019Q3	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	53836000	USD
CY2018Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	54008000	USD
CY2019Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43003000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	46694000	USD
CY2019Q3	ams	Number Of Debt Instruments NumberOfDebtInstruments	7	note
CY2019Q3	us-gaap	Long Term Debt LongTermDebt	3896000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5917000	shares
CY2019Q3	ams	Number Of Financing Leases NumberOfFinancingLeases	10	lease
CY2019Q3	us-gaap	Capital Lease Obligations CapitalLeaseObligations	12853000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.060
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1173000	USD
CY2019Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1173000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	84000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	340000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	347000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	331000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	214000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	6000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1322000	USD
CY2019Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	149000	USD
CY2019Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1173000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	165000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	168000	USD
	us-gaap	Net Income Loss NetIncomeLoss	466000	USD
	us-gaap	Net Income Loss NetIncomeLoss	845000	USD
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5889000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5841000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5899000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5831000	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	19000	shares
CY2018Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	50000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	18000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	24000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5908000	shares
CY2018Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5891000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	478000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.86
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5855000	shares
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	62000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	170000	USD
CY2018Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	57000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	169000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P5Y
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	108000	USD
CY2019Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	434000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.85
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M4D
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	18000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.91
	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodOutstandingWeightedAverageRemainingContractualTerm	P7Y
	ams	Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Intrinsic Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodIntrinsicValue	0	USD
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	16000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	2.59
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.05
	ams	Sharebased Compensation Arrangementby Sharebased Payment Award Options Forfeituresin Period Intrinsic Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresinPeriodIntrinsicValue	0	USD
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	603000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.86
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y1M2D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y11M19D
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	615000	shares
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.87
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y5M23D
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.68
	ams	Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants In Period Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodOutstandingWeightedAverageRemainingContractualTerm	P6Y11M15D
	ams	Sharebased Compensation Arrangementby Sharebased Payment Award Options Grantsin Period Intrinsic Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsGrantsinPeriodIntrinsicValue	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	18000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.15
	ams	Sharebased Compensation Arrangementby Sharebased Payment Award Options Forfeituresin Period Intrinsic Value SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsForfeituresinPeriodIntrinsicValue	0	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.85
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y11M4D
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	337000	USD
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	389000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.86
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M29D
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD

Files In Submission

Name	View Source	Status
0000744825-19-000008-index-headers.html	Edgar Link	pending
0000744825-19-000008-index.html	Edgar Link	pending
0000744825-19-000008.txt	Edgar Link	pending
0000744825-19-000008-xbrl.zip	Edgar Link	pending
ams-20190930.htm	Edgar Link	pending
ams-20190930.xsd	Edgar Link	pending
ams-20190930_cal.xml	Edgar Link	unprocessable
ams-20190930_def.xml	Edgar Link	unprocessable
ams-20190930_htm.xml	Edgar Link	completed
ams-20190930_lab.xml	Edgar Link	unprocessable
ams-20190930_pre.xml	Edgar Link	unprocessable
ams09-30x2019xex312.htm	Edgar Link	pending
ams09-30x2019xex321.htm	Edgar Link	pending
ams09-30x2019xexx311.htm	Edgar Link	pending
ex101.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2019 Q4 Form 10-Q Financial Statement

#000074482519000008 Filed on November 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS AMERICAN SHARED HOSPITAL SERVICES Stock $ams

2019 Q4 Form 10-Q Financial Statement

#000074482519000008 Filed on November 07, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMS
AMERICAN SHARED HOSPITAL SERVICES Stock $ams